Incyte Corp (INCY)
53.76
+0.67
(+1.26%)
USD |
NASDAQ |
May 03, 16:00
53.78
+0.02
(+0.04%)
After-Hours: 20:00
Incyte Debt to Equity Ratio: 0.00 for March 31, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
March 31, 2024 | 0.00 |
December 31, 2023 | 0.00 |
September 30, 2023 | 0.00 |
June 30, 2023 | 0.00 |
March 31, 2023 | 0.00 |
December 31, 2022 | 0.00 |
September 30, 2022 | 0.00 |
June 30, 2022 | 0.00 |
March 31, 2022 | 0.00 |
December 31, 2021 | 0.00 |
September 30, 2021 | 0.00 |
June 30, 2021 | 0.00 |
March 31, 2021 | 0.00 |
December 31, 2020 | 0.00 |
September 30, 2020 | 0.005 |
June 30, 2020 | 0.0079 |
March 31, 2020 | 0.0096 |
December 31, 2019 | 0.007 |
September 30, 2019 | 0.0075 |
June 30, 2019 | 0.0079 |
March 31, 2019 | 0.0085 |
December 31, 2018 | 0.0091 |
September 30, 2018 | 0.0138 |
June 30, 2018 | 0.0142 |
March 31, 2018 | 0.0149 |
Date | Value |
---|---|
December 31, 2017 | 0.0147 |
September 30, 2017 | 0.0135 |
June 30, 2017 | 0.0228 |
March 31, 2017 | 0.0431 |
December 31, 2016 | 1.553 |
September 30, 2016 | 1.739 |
June 30, 2016 | 2.139 |
March 31, 2016 | 2.756 |
December 31, 2015 | 3.622 |
September 30, 2015 | 7.031 |
June 30, 2015 | 11.96 |
March 31, 2015 | -16.84 |
December 31, 2014 | -8.271 |
September 30, 2014 | -7.605 |
June 30, 2014 | -3.938 |
March 31, 2014 | -4.096 |
December 31, 2013 | -3.426 |
September 30, 2013 | 6.500 |
June 30, 2013 | -8.055 |
March 31, 2013 | -2.064 |
December 31, 2012 | -1.892 |
September 30, 2012 | -1.521 |
June 30, 2012 | -1.512 |
March 31, 2012 | -1.295 |
December 31, 2011 | -1.392 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Dec 2020
0.0096
Maximum
Mar 2020
0.0022
Average
--
Median
Dec 2020
Debt to Equity Ratio Benchmarks
Biogen Inc | 0.4299 |
Novartis AG | 0.6435 |
MorphoSys AG | 12.71 |
Illumina Inc | 0.2592 |
Pfizer Inc | 0.7959 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 7.136B |
Total Liabilities (Quarterly) | 1.741B |
Shareholders Equity (Quarterly) | 5.394B |
Current Ratio | 3.472 |